MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X)) Recall
Recall Date
Sep 16, 2026
Company
Nipro Renal Soultions USA, Corporation
Source
FDA
Units
2,327 cases
Reason: Hemodialysis concentrates contain high endotoxin levels
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Description
Hemodialysis concentrates contain high endotoxin levels
Reason for Recall
Hemodialysis concentrates contain high endotoxin levels
What Should I Do?
Quantity: 2,327 cases
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
+2 more steps…
Last updated September 22, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.